Immunocytokines for the treatment of cancer
US11673931B2 · kind B2 · utility
0Cited by
13References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 1, 2020 |
| Grant date | Jun 13, 2023 |
| Priority date | — |
| Expiry date | Mar 14, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/75
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to new immunocytokines which are useful for the treatment of cancer. These fusion proteins comprise (i) an antibody or antigen-binding fragment thereof fused to (ii) a cleavable peptide linker, and (iii) cytokine, or functional fragments thereof. Methods of treatment using these immunocytokines are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.